Jinny Ha

Medicine & Life Sciences

1. Lung Transplantation 100%
2. Transplants 71%
3. Lung 56%
4. Composite Tissue Allografts 40%
5. Extracorporeal Membrane Oxygenation 39%
6. Esophageal Neoplasms 35%
7. Sympathectomy 31%
8. Primates 31%
9. Vascularized Composite Allotransplantation 29%
10. Tissue Donors 28%
11. Non-Small Cell Lung Carcinoma 25%
12. Mortality 25%
13. Allografts 25%
14. Coronavirus 21%
15. Perfusion 19%
16. Esophagectomy 17%
17. Hepatitis C 17%
18. Transplant Recipients 17%
19. Cystic Fibrosis 16%
20. Survival 16%
21. Immunotherapy 15%
22. Nivolumab 13%
23. Transplantation 13%
24. Lung Neoplasms 13%
25. Guanfacine 13%
26. Primary Dysautonomias 12%
27. Bone Marrow 12%
28. Epigastric Arteries 12%
29. Mutation 12%
30. Ipilimumab 11%
31. Immunosuppression 11%
32. Cardiac Arrhythmias 11%
33. Physician Assistants 11%
34. Thorax 10%
35. Severe Acute Respiratory Syndrome 10%
36. Tumor-Infiltrating Lymphocytes 10%
37. Registries 10%
38. Thoracoscopy 10%
39. Lymphopenia 10%
40. Confidence Intervals 10%
41. Adult Respiratory Distress Syndrome 10%
42. Anastomotic Leak 10%
43. Robotics 9%
44. Graft Survival 9%
45. Chronic Obstructive Pulmonary Disease 9%
46. Length of Stay 9%
47. Optical Imaging 9%
48. Sarcoidosis 9%